Aberrant expression of selenium-containing glutathione peroxidases in clear cell renal cell carcinomas

Experimental Oncology

Volumn 37, Issue 2, 2015, Pages 105-110

  Rudenko, E ^a   Kondratov, O ^a   Gerashchenko, G ^a   Lapska, Y ^a   Kravchenko, S ^a   Koliada, O ^b   Vozianov, S ^b   Zgonnyk, Y ^b   Kashuba, V ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

^b STATE INSTITUTION NATIONAL RESEARCH CENTER FOR RADIATION MEDICINE OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE   (Ukraine)

Author keywords

Clear cell renal cell carcinomas; Genetic and epigenetic regulation; Selenium containing GPXs

Indexed keywords

ALANINE; GLUTATHIONE PEROXIDASE 1; GLUTATHIONE PEROXIDASE 3; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE; SELENIUM; GLUTATHIONE PEROXIDASE; GPX3 PROTEIN, HUMAN; PHOSPHOLIPID-HYDROPEROXIDE GLUTATHIONE PEROXIDASE;

ADULT; ALLELE; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE DOSAGE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; METHYLATION; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; CARCINOGENESIS; ENZYMOLOGY; GENE EXPRESSION; GENETICS; KIDNEY TUMOR; METABOLISM; MIDDLE AGED; TUMOR CELL LINE;

CARCINOGENESIS; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION; GLUTATHIONE PEROXIDASE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED;

EID: 84933510136     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: 10.31768/2312-8852.2015.37(2):105-110     Document Type: Article

References (33)

1. Tannir NM. Renal cell carcinoma. Oxford: Oxford University Press, 2014.
2. Nogueira V, Hay N. Molecular pathways: reactive oxygen species homeostasis in cancer cells and implications for cancer therapy. Clinical Cancer Res 2013; 19: 4309-14.
3. Brigelius-Flohé R, Maiorino M. Glutathione peroxidases. Biochim Biophys Acta 2013; 1830: 3289-303.
4. Lubos E, Loscalzo J, Handy D. Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 2011; 15: 1957-97.
5. Zhuo P, Goldberg M, Herman L, et al. Molecular consequences of genetic variations in the glutathione peroxidase 1 selenoenzyme. Cancer Res 2009; 69: 8183-90.
6. Naiki-Ito A, Asamoto M, Hokaiwado N, et al. Gpx2 is an overexpressed gene in rat breast cancers induced by three different chemical carcinogens. Cancer Res 2007; 67: 11353-8.
7. Murawaki Y, Tsuchiya H, Kanbe T, et al. Aberrant expression of selenoproteins in the progression of colorectal cancer. Cancer Lett 2008; 259: 218-30.
8. Lin Y, Furukawa Y, Tsunoda T, et al. Molecular diagnosis of colorectal tumors by expression profiles of 50 genes expressed differentially in adenomas and carcinomas. Oncogene 2002; 21: 4120-8.
9. Yu Y, Yu G, Tseng G, et al. Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis. Cancer Res 2007; 67: 8043-50.
10. Liu J, Du J, Zhang Y, et al. Suppression of the malignant phenotype in pancreatic cancer by overexpression of phospholipid hydroperoxide glutathione peroxidase. Hum Gene Ther 2006; 17: 105-16.
11. Speissel B, Beahrs O, Hermanek P, et al. TNM atlas: illustrated guide to the TNM/pTNM classification of malignant tumours Berlin. New York: Springer, 1989. 343 p.
12. Travis W, Coby T, Corrin B, et al. World Health Organization International histological classification of tumours; histological typing of lung and pleural tumours. Berlin: Springer, 1999. 156 p.
13. Jung M, Ramankulov A, Roigas J, et al. In search of suitable reference genes for gene expression studies of human renal cell carcinoma by real-time PCR. BMC Mol Biol 2007; 8: 47-9.
14. Gerashchenko G, Bogatyrova O, Rudenko E, et al. Genetic and epigenetic changes of NKIRAS1 gene in human renal cell carcinomas. Exp Oncol 2010; 32: 71-5.
15. Rousset F. Genepop'007: a complete reimplementation of the Genepop software for exact tests for Windows and Linux. Mol Ecol Resour 2008; 8: 103-6.
16. Brigelius-Flohé R, Kipp A, Liu J, et al. Glutathione peroxidases in different stages of carcinogenesis. In: Human Gene Therapy, 2004: 239-50.
17. Zhuo P, Diamond A. Molecular mechanisms by which selenoproteins affect cancer risk and progression. Biochim Biophys Acta 2009; 1790: 1546-54.
18. Kote-Jarai Z, Durocher F, Edwards SM, et al. Association between the GCG polymorphism of the selenium dependent GPX1 gene and the risk of young onset prostate cancer. Prostate Cancer Prostatic Diseases 2002; 5: 189-92.
19. Brigelius-Flohé R, Kipp AP. Physiological functions of GPx2 and its role in inflammation-triggered carcinogenesis. Ann NY Acad Sci 2012; 1259: 19-25.
20. Florian S, Wingler K, Schmehl K, et al. Cellular and subcellular localization of gastrointestinal glutathione peroxidase in normal and malignant human intestinal tissue. Free Radic Res 2001; 35: 655-63.
21. Mohamed M, Sabet S, Peng DF, et al. Promoter hypermethylation and suppression of glutathione peroxidase 3 are associated with inflammatory breast carcinogenesis. Oxidative Medicine and Cellular Longevity 2014; 2014 (http://dx.doi.org/10.1155/2014/787195).
22. Pawlowicz Z, Zachara B, Trafikowska U, et al. Blood selenium concentrations and glutathione peroxidase activities in patients with breast cancer and with advanced gastrointestinal cancer. J Trace Elem Electrolytes Health Dis 1991; 5: 275-7.
23. Cole-Ezea P, Swan D, Shanley D, et al. Glutathione peroxidase 4 has a major role in protecting mitochondria from oxidative damage and maintaining oxidative phosphorylation complexes in gut epithelial cells. Free Radical Biol Med 2012; 53: 488-97.
24. Imai H, Hirao F, Sakamoto T, et al. Early embryonic lethality caused by targeted disruption of the mouse PHGPx gene. Biochem Biophys Res Commun 2003; 305: 278-86.
25. Kryukov G, Castellano S, Novoselov S, et al. Characterization of mammalian selenoproteomes. Science 2003; 300: 1439-43.
26. Cerami E, Gao J, Dogrusoz U, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2012; 2: 401-4.
27. Gao J, Aksoy BA, Dogrusoz G, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 2013; 6: p11.
28. Koch C, Evans S. Optimizing hypoxia detection and treatment strategies. Semin Nucl Med 2015; 45: 163-76.
29. Merante F, Altamentova S, Mickle D, et al. The characterization and purification of a human transcription factor modulating the glutathione peroxidase gene in response to oxygen tension. Mol Cell Biochem 2002; 229: 73-83.
30. Jornot L, Junod A. Hyperoxia, unlike phorbol ester, induces glutathione peroxidase through a protein kinase C-independent mechanism. Biochem J 1997; 326: 117-23.
31. Rudenko E, Gerashchenko G, Lapska Y, et al. Genetic and epigenetic changes of GPX1 and GPX3 in human clearcell renal cell carcinoma. Biopolym Cell 2013; 29: 395-401.
32. Sablina A, Budanov A, Ilyinskaya G, et al. The antioxidant function of the p53 tumor suppressor. Nat Med 2005; 11: 1306-13.
33. Tan M, Li S, Swaroop M, et al. Transcriptional activation of the human glutathione peroxidase promoter by p53. Biol Chem 1999; 274: 12061-6.